NCT04098627

The Effects of Laughter Therapy on Hemodialysis on Depression

The Effects of Laughter Therapy on Hemodialysis on Depression: A Pragmatic Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 152 (actual)
• Sponsor: Satellite Healthcare · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

End stage kidney disease is associated with increased depression. Laughter is associated with improvement in depression in chronic disease. The study objective was to measure the effect of intradialytic group laughter therapy on anxiety and depression. Pragmatic randomized controlled trial conducted in 10 hemodialysis centers in Northern California. The intervention group received a once weekly 30-minute long group laughter therapy session for 8 weeks. Primary outcome was depression score as measured using the Patient Health Questionnaire.

Conditions

• End Stage Kidney Disease

Interventions

Type	Name	Description
BEHAVIORAL	Laughter Therapy	Once weekly 30-minute long group laughter therapy session for 8 weeks

Timeline

• Start date: 2018-04-01
• Primary completion: 2018-05-07
• Completion: 2019-03-28
• First posted: 2019-09-23
• Last updated: 2019-10-03

Locations

1 site across 1 country: United States